{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T19:43:21Z","timestamp":1794512601237,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T00:00:00Z","timestamp":1525046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T00:00:00Z","timestamp":1525046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Once activated, the intracellular receptor NLRP3 assembles an inflammasome protein complex that facilitates the caspase-1-mediated maturation of IL-1\u03b2 and IL-18. Inactive NLRP3 is guarded by a protein complex containing Hsp90. In response to stress stimuli, Hsp90 is released, and NLRP3 can be activated to promote inflammation. In this study, we blocked Hsp90 with geldanamycin and studied the fate of NLRP3 in human retinal pigment epithelial (RPE) cells. RPE cells play a central role in the development of age-related macular degeneration (AMD), a progressive eye disease causing severe vision loss in the elderly. IL-1\u03b1-primed ARPE-19 cells, human embryonal stem cell (hESC)-derived RPE cells, and primary human RPE cells were exposed to MG-132 and bafilomycin A to activate NLRP3 via the inhibition of proteasomes and autophagy, respectively. Additionally, RPE cells were treated with geldanamycin at different time points and the levels of NLRP3 and IL-1\u03b2 were determined. Caspase-1 activity was measured using a commercial assay. Geldanamycin prevented the activation of the inflammasome in human RPE cells. NLRP3 released from its protective complex became degraded by autophagy or secreted from the cells. Controlled destruction of NLRP3 is a potential way to regulate the inflammation associated with chronic diseases, such as AMD.<\/jats:p>","DOI":"10.1038\/s41598-018-25123-2","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T09:18:13Z","timestamp":1524561493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Hsp90 inhibition as a means to inhibit activation of the NLRP3 inflammasome"],"prefix":"10.1038","volume":"8","author":[{"given":"Niina","family":"Piippo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveliina","family":"Korhonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Hytti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli","family":"Skottman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kati","family":"Kinnunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Josifovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goran","family":"Petrovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Kaarniranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8254-0200","authenticated-orcid":false,"given":"Anu","family":"Kauppinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,30]]},"reference":[{"key":"25123_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","volume":"27","author":"F Martinon","year":"2009","unstructured":"Martinon, F., Mayor, A. & Tschopp, J. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27, 229\u2013265 (2009).","journal-title":"Annu. Rev. Immunol."},{"key":"25123_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/nyas.12458","volume":"1319","author":"FS Sutterwala","year":"2014","unstructured":"Sutterwala, F. S., Haasken, S. & Cassel, S. L. Mechanism of NLRP3 inflammasome activation. Ann. N. Y. Acad. Sci. 1319, 82\u201395 (2014).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"25123_CR3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1167\/iovs.12-10655","volume":"54","author":"WA Tseng","year":"2013","unstructured":"Tseng, W. A. et al. NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 54, 110\u2013120 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"25123_CR4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/cmi.2015.95","volume":"13","author":"EK Jo","year":"2016","unstructured":"Jo, E. K., Kim, J. K., Shin, D. M. & Sasakawa, C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell. Mol. Immunol. 13, 148\u2013159 (2016).","journal-title":"Cell. Mol. Immunol."},{"key":"25123_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4161\/auto.7.3.14583","volume":"7","author":"G Petrovski","year":"2011","unstructured":"Petrovski, G. et al. Phagocytosis of cells dying through autophagy induces inflammasome activation and IL-1beta release in human macrophages. Autophagy 7, 321\u2013330 (2011).","journal-title":"Autophagy"},{"key":"25123_CR6","doi-asserted-by":"publisher","first-page":"e40069","DOI":"10.1371\/journal.pone.0040069","volume":"7","author":"G Ayna","year":"2012","unstructured":"Ayna, G. et al. ATP release from dying autophagic cells and their phagocytosis are crucial for inflammasome activation in macrophages. PLoS One 7, e40069 (2012).","journal-title":"PLoS One"},{"key":"25123_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nature10759","volume":"481","author":"T Strowig","year":"2012","unstructured":"Strowig, T., Henao-Mejia, J., Elinav, E. & Flavell, R. Inflammasomes in health and disease. Nature 481, 278\u2013286 (2012).","journal-title":"Nature"},{"key":"25123_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/jcm4010172","volume":"4","author":"L Celkova","year":"2015","unstructured":"Celkova, L., Doyle, S. L. & Campbell, M. NLRP3 Inflammasome and Pathobiology in AMD. J. Clin. Med. 4, 172\u2013192 (2015).","journal-title":"J. Clin. Med."},{"key":"25123_CR9","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00018-016-2147-8","volume":"73","author":"A Kauppinen","year":"2016","unstructured":"Kauppinen, A., Paterno, J. J., Blasiak, J., Salminen, A. & Kaarniranta, K. Inflammation and its role in age-related macular degeneration. Cell Mol. Life Sci. 73, 1765\u20131786 (2016).","journal-title":"Cell Mol. Life Sci."},{"key":"25123_CR10","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong, W. L. et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob. Health. 2, e106\u201316 (2014).","journal-title":"Lancet Glob. Health."},{"key":"25123_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/IAE.0000000000000036","volume":"34","author":"R Velez-Montoya","year":"2014","unstructured":"Velez-Montoya, R. et al. Current knowledge and trends in age-related macular degeneration: genetics, epidemiology, and prevention. Retina 34, 423\u2013441 (2014).","journal-title":"Retina"},{"key":"25123_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2147\/OPTH.S59724","volume":"9","author":"E Buschini","year":"2015","unstructured":"Buschini, E. et al. Recent developments in the management of dry age-related macular degeneration. Clin. Ophthalmol. 9, 563\u2013574 (2015).","journal-title":"Clin. Ophthalmol."},{"key":"25123_CR13","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrm2918","volume":"11","author":"M Taipale","year":"2010","unstructured":"Taipale, M., Jarosz, D. F. & Lindquist, S. HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat. Rev. Mol. Cell Biol. 11, 515\u2013528 (2010).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"25123_CR14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/ni1459","volume":"8","author":"A Mayor","year":"2007","unstructured":"Mayor, A., Martinon, F., De Smedt, T., Petrilli, V. & Tschopp, J. A crucial function of SGT1 and HSP90 in inflammasome activity links mammalian and plant innate immune responses. Nat. Immunol. 8, 497\u2013503 (2007).","journal-title":"Nat. Immunol."},{"key":"25123_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00281-007-0079-y","volume":"29","author":"F Martinon","year":"2007","unstructured":"Martinon, F., Gaide, O., Petrilli, V., Mayor, A. & Tschopp, J. NALP inflammasomes: a central role in innate immunity. Semin. Immunopathol. 29, 213\u2013229 (2007).","journal-title":"Semin. Immunopathol."},{"key":"25123_CR16","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1189\/jlb.0607362","volume":"83","author":"F Martinon","year":"2008","unstructured":"Martinon, F. Detection of immune danger signals by NALP3. J. Leukoc. Biol. 83, 507\u2013511 (2008).","journal-title":"J. Leukoc. Biol."},{"key":"25123_CR17","doi-asserted-by":"publisher","first-page":"9587","DOI":"10.1074\/jbc.M110.202911","volume":"286","author":"J Harris","year":"2011","unstructured":"Harris, J. et al. Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J. Biol. Chem. 286, 9587\u20139597 (2011).","journal-title":"J. Biol. Chem."},{"key":"25123_CR18","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1016\/j.bbamcr.2014.09.015","volume":"1843","author":"N Piippo","year":"2014","unstructured":"Piippo, N. et al. Decline in cellular clearance systems induces inflammasome signaling in human ARPE-19 cells. Biochim. Biophys. Acta 1843, 3038\u20133046 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"25123_CR19","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s11626-010-9286-2","volume":"46","author":"H Skottman","year":"2010","unstructured":"Skottman, H. Derivation and characterization of three new human embryonic stem cell lines in Finland. In Vitro Cell. Dev. Biol. Anim. 46, 206\u2013209 (2010).","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"25123_CR20","first-page":"558","volume":"17","author":"H Vaajasaari","year":"2011","unstructured":"Vaajasaari, H. et al. Toward the defined and xeno-free differentiation of functional human pluripotent stem cell-derived retinal pigment epithelial cells. Mol. Vis. 17, 558\u2013575 (2011).","journal-title":"Mol. Vis."},{"key":"25123_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.133","volume":"7","author":"M Szatmari-Toth","year":"2016","unstructured":"Szatmari-Toth, M. et al. Clearance of autophagy-associated dying retinal pigment epithelial cells - a possible source for inflammation in age-related macular degeneration. Cell. Death Dis. 7, e2367 (2016).","journal-title":"Cell. Death Dis."},{"key":"25123_CR22","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248\u2013254 (1976).","journal-title":"Anal. Biochem."},{"key":"25123_CR23","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1111\/bph.12856","volume":"172","author":"MJ Curtis","year":"2015","unstructured":"Curtis, M. J. et al. Experimental design and analysis and their reporting: new guidance for publication in BJP. Br. J. Pharmacol. 172, 3461\u20133471 (2015).","journal-title":"Br. J. Pharmacol."},{"key":"25123_CR24","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon, F., Burns, K. & Tschopp, J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 10, 417\u2013426 (2002).","journal-title":"Mol. Cell"},{"key":"25123_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nature02664","volume":"430","author":"S Mariathasan","year":"2004","unstructured":"Mariathasan, S. et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430, 213\u2013218 (2004).","journal-title":"Nature"},{"key":"25123_CR26","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.cell.2004.05.004","volume":"117","author":"F Martinon","year":"2004","unstructured":"Martinon, F. & Tschopp, J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117, 561\u2013574 (2004).","journal-title":"Cell"},{"key":"25123_CR27","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.cub.2007.05.074","volume":"17","author":"L Feldmeyer","year":"2007","unstructured":"Feldmeyer, L. et al. The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr. Biol. 17, 1140\u20131145 (2007).","journal-title":"Curr. Biol."},{"key":"25123_CR28","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.cell.2007.12.040","volume":"132","author":"M Keller","year":"2008","unstructured":"Keller, M., Ruegg, A., Werner, S. & Beer, H. D. Active caspase-1 is a regulator of unconventional protein secretion. Cell 132, 818\u2013831 (2008).","journal-title":"Cell"},{"key":"25123_CR29","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/ncb2784","volume":"15","author":"JC Acosta","year":"2013","unstructured":"Acosta, J. C. et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat. Cell Biol. 15, 978\u2013990 (2013).","journal-title":"Nat. Cell Biol."},{"key":"25123_CR30","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/ni.2919","volume":"15","author":"A Baroja-Mazo","year":"2014","unstructured":"Baroja-Mazo, A. et al. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat. Immunol. 15, 738\u2013748 (2014).","journal-title":"Nat. Immunol."},{"key":"25123_CR31","doi-asserted-by":"publisher","first-page":"973","DOI":"10.4161\/auto.24546","volume":"9","author":"K Kaarniranta","year":"2013","unstructured":"Kaarniranta, K. et al. Autophagy and heterophagy dysregulation leads to retinal pigment epithelium dysfunction and development of age-related macular degeneration. Autophagy 9, 973\u2013984 (2013).","journal-title":"Autophagy"},{"key":"25123_CR32","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cell.2012.03.036","volume":"149","author":"V Tarallo","year":"2012","unstructured":"Tarallo, V. et al. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell 149, 847\u2013859 (2012).","journal-title":"Cell"},{"key":"25123_CR33","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nm.2717","volume":"18","author":"SL Doyle","year":"2012","unstructured":"Doyle, S. L. et al. NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nat. Med. 18, 791\u2013798 (2012).","journal-title":"Nat. Med."},{"key":"25123_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.imlet.2012.05.005","volume":"147","author":"A Kauppinen","year":"2012","unstructured":"Kauppinen, A. et al. Oxidative stress activates NLRP3 inflammasomes in ARPE-19 cells\u2013implications for age-related macular degeneration (AMD). Immunol. Lett. 147, 29\u201333 (2012).","journal-title":"Immunol. Lett."},{"key":"25123_CR35","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1167\/iovs.14-14557","volume":"56","author":"G Shi","year":"2015","unstructured":"Shi, G. et al. Inflammasomes Induced by 7-Ketocholesterol and Other Stimuli in RPE and in Bone Marrow-Derived Cells Differ Markedly in Their Production of IL-1beta and IL-18. Invest. Ophthalmol. Vis. Sci. 56, 1658\u20131664 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"25123_CR36","doi-asserted-by":"publisher","first-page":"736905","DOI":"10.1155\/2012\/736905","volume":"2012","author":"T Lamark","year":"2012","unstructured":"Lamark, T. & Johansen, T. Aggrephagy: selective disposal of protein aggregates by macroautophagy. Int. J. Cell. Biol. 2012, 736905 (2012).","journal-title":"Int. J. Cell. Biol."},{"key":"25123_CR37","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neulet.2006.11.052","volume":"413","author":"JW Park","year":"2007","unstructured":"Park, J. W. et al. Differential expression of heat shock protein mRNAs under in vivo glutathione depletion in the mouse retina. Neurosci. Lett. 413, 260\u2013264 (2007).","journal-title":"Neurosci. Lett."},{"key":"25123_CR38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrneurol.2011.200","volume":"8","author":"H Harris","year":"2011","unstructured":"Harris, H. & Rubinsztein, D. C. Control of autophagy as a therapy for neurodegenerative disease. Nat. Rev. Neurol. 8, 108\u2013117 (2011).","journal-title":"Nat. Rev. Neurol."},{"key":"25123_CR39","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.exger.2008.08.052","volume":"43","author":"Y Li","year":"2008","unstructured":"Li, Y. et al. Alterations of activity and intracellular distribution of the 20S proteasome in ageing retinal pigment epithelial cells. Exp. Gerontol. 43, 1114\u20131122 (2008).","journal-title":"Exp. Gerontol."},{"key":"25123_CR40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.mam.2009.04.001","volume":"30","author":"T Jung","year":"2009","unstructured":"Jung, T., Catalgol, B. & Grune, T. The proteasomal system. Mol. Aspects Med. 30, 191\u2013296 (2009).","journal-title":"Mol. Aspects Med."},{"key":"25123_CR41","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1755-3768.2011.02179.x","volume":"90","author":"K Kinnunen","year":"2012","unstructured":"Kinnunen, K., Petrovski, G., Moe, M. C., Berta, A. & Kaarniranta, K. Molecular mechanisms of retinal pigment epithelium damage and development of age-related macular degeneration. Acta Ophthalmol. 90, 299\u2013309 (2012).","journal-title":"Acta Ophthalmol."},{"key":"25123_CR42","first-page":"007","volume":"2013","author":"A Carman","year":"2013","unstructured":"Carman, A., Kishinevsky, S., Koren, J. 3rd, Lou, W. & Chiosis, G. Chaperone-dependent Neurodegeneration: A Molecular Perspective on Therapeutic Intervention. J. Alzheimers Dis. Parkinsonism 2013, 007 (2013).","journal-title":"J. Alzheimers Dis. Parkinsonism"},{"key":"25123_CR43","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.exer.2011.10.002","volume":"93","author":"S Qin","year":"2011","unstructured":"Qin, S. et al. Inhibition of RPE cell sterile inflammatory responses and endotoxin-induced uveitis by a cell-impermeable HSP90 inhibitor. Exp. Eye Res. 93, 889\u2013897 (2011).","journal-title":"Exp. Eye Res."},{"key":"25123_CR44","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.molbrainres.2005.02.027","volume":"137","author":"K Kaarniranta","year":"2005","unstructured":"Kaarniranta, K. et al. Geldanamycin activates Hsp70 response and attenuates okadaic acid-induced cytotoxicity in human retinal pigment epithelial cells. Brain Res. Mol. Brain Res. 137, 126\u2013131 (2005).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"25123_CR45","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.exer.2007.08.005","volume":"85","author":"WC Wu","year":"2007","unstructured":"Wu, W. C., Kao, Y. H., Hu, P. S. & Chen, J. H. Geldanamycin, a HSP90 inhibitor, attenuates the hypoxia-induced vascular endothelial growth factor expression in retinal pigment epithelium cells in vitro. Exp. Eye Res. 85, 721\u2013731 (2007).","journal-title":"Exp. Eye Res."},{"key":"25123_CR46","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s11033-009-9490-x","volume":"37","author":"YQ Wang","year":"2010","unstructured":"Wang, Y. Q., Zhang, X. M., Wang, X. D., Wang, B. J. & Wang, W. 17-AAG, a Hsp90 inhibitor, attenuates the hypoxia-induced expression of SDF-1alpha and ILK in mouse RPE cells. Mol. Biol. Rep. 37, 1203\u20131209 (2010).","journal-title":"Mol. Biol. Rep."},{"key":"25123_CR47","doi-asserted-by":"publisher","first-page":"798052","DOI":"10.1155\/2011\/798052","volume":"2011","author":"T Ryhanen","year":"2011","unstructured":"Ryhanen, T. et al. Influence of Hsp90 and HDAC inhibition and tubulin acetylation on perinuclear protein aggregation in human retinal pigment epithelial cells. J. Biomed. Biotechnol. 2011, 798052 (2011).","journal-title":"J. Biomed. Biotechnol."},{"key":"25123_CR48","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1096\/fj.06-7637com","volume":"21","author":"V Poulaki","year":"2007","unstructured":"Poulaki, V. et al. Inhibition of Hsp90 attenuates inflammation in endotoxin-induced uveitis. FASEB J. 21, 2113\u20132123 (2007).","journal-title":"FASEB J."},{"key":"25123_CR49","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1093\/hmg\/ddq369","volume":"19","author":"LC Tam","year":"2010","unstructured":"Tam, L. C. et al. Prevention of autosomal dominant retinitis pigmentosa by systemic drug therapy targeting heat shock protein 90 (Hsp90). Hum. Mol. Genet. 19, 4421\u20134436 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"25123_CR50","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1093\/hmg\/ddt613","volume":"23","author":"M Aguila","year":"2014","unstructured":"Aguila, M. et al. Hsp90 inhibition protects against inherited retinal degeneration. Hum. Mol. Genet. 23, 2164\u20132175 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"25123_CR51","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ejca.2009.10.026","volume":"46","author":"S Kummar","year":"2010","unstructured":"Kummar, S. et al. Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies. Eur. J. Cancer 46, 340\u2013347 (2010).","journal-title":"Eur. J. Cancer"},{"key":"25123_CR52","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1158\/1078-0432.CCR-10-1927","volume":"17","author":"S Pacey","year":"2011","unstructured":"Pacey, S. et al. A phase I study of the heat shock protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced solid tumors. Clin. Cancer Res. 17, 1561\u20131570 (2011).","journal-title":"Clin. Cancer Res."},{"key":"25123_CR53","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1158\/1078-0432.CCR-12-3404","volume":"19","author":"C Sessa","year":"2013","unstructured":"Sessa, C. et al. First-in-human phase I dose-escalation study of the HSP90 inhibitor AUY922 in patients with advanced solid tumors. Clin. Cancer Res. 19, 3671\u20133680 (2013).","journal-title":"Clin. Cancer Res."},{"key":"25123_CR54","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1158\/1078-0432.CCR-14-0979","volume":"21","author":"GI Shapiro","year":"2015","unstructured":"Shapiro, G. I. et al. First-in-human phase I dose escalation study of a second-generation non-ansamycin HSP90 inhibitor, AT13387, in patients with advanced solid tumors. Clin. Cancer Res. 21, 87\u201397 (2015).","journal-title":"Clin. Cancer Res."},{"key":"25123_CR55","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1158\/1535-7163.MCT-14-0219","volume":"14","author":"S Ohkubo","year":"2015","unstructured":"Ohkubo, S. et al. TAS-116, a highly selective inhibitor of heat shock protein 90alpha and beta, demonstrates potent antitumor activity and minimal ocular toxicity in preclinical models. Mol. Cancer. Ther. 14, 14\u201322 (2015).","journal-title":"Mol. Cancer. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25123-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25123-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25123-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:54:04Z","timestamp":1671598444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25123-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,30]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["25123"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-25123-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,30]]},"assertion":[{"value":"4 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6720"}}